Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
announces
.
Show all posts
Showing posts with label
announces
.
Show all posts
Monday, July 20, 2026
Egetis Announces FDA Acceptance and Priority Review of NDA for Emcitate (tiratricol) for MCT8 Deficiency
›
Egetis Therapeutics AB (publ) (“Egetis” or the “Company”) (NASDAQ Stockholm: EGTX), today announced that the U.S. Food and Drug Administrati...
Tuesday, June 30, 2026
Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs
›
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmace...
Monday, June 29, 2026
Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma Treatment
›
Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevat...
Tuesday, June 16, 2026
Lilly's announces results from Phase III clinical trial of Jaypirca
›
In continuation of my update on pirtobrutinib Eli Lilly and Company announced results from the Phase 3 BRUIN CLL-322 clinical trial of Jayp...
›
Home
View web version
